Qube Research & Technologies (QRT)
MRNA icon

Qube Research & Technologies (QRT)’s Moderna MRNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.6M Buy
+700,692
New +$32.7M 0.04% 566
2025
Q1 		– Sell
-293,652
Closed -$10.4M – 3733
2024
Q4 		$12.2M Buy
293,652
+252,618
+616% +$12.1M 0.02% 978
2024
Q3 		$2.74M Sell
41,034
-123,769
-75% -$11.4M ﹤0.01% 1636
2024
Q2 		$19.6M Buy
164,803
+150,261
+1,033% +$19M 0.03% 611
2024
Q1 		$1.55M Buy
+14,542
New +$1.47M ﹤0.01% 1888
2023
Q2 		– Sell
-90,885
Closed -$14M – 2778
2023
Q1 		$14M Sell
90,885
-118,873
-57% -$19.6M 0.06% 352
2022
Q4 		$37.7M Buy
+209,758
New +$34.3M 0.2% 119
2022
Q3 		– Sell
-137,017
Closed -$19.6M – 2825
2022
Q2 		$19.6M Buy
+137,017
New +$19.6M 0.14% 183
2022
Q1 		– Sell
-45,298
Closed -$11.5M – 2795
2021
Q4 		$11.5M Buy
45,298
+22,293
+97% +$6.52M 0.09% 299
2021
Q3 		$8.85M Sell
23,005
-20,504
-47% -$7.56M 0.11% 224
2021
Q2 		$10.2M Buy
+43,509
New +$7.78M 0.12% 205
2021
Q1 		– Sell
-320,820
Closed -$33.5M – 2231
2020
Q4 		$33.5M Buy
+320,820
New +$32.5M 0.48% 28
2020
Q2 		– Sell
-35,280
Closed -$1.06M – 1898
2020
Q1 		$1.06M Buy
+35,280
New +$812K 0.04% 373

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRNA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Moderna (MRNA) in Q1 2026: 700,692 shares worth $35.6M. The stake represents 0.04% of the portfolio and ranks #566 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRNA as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in MRNA in Q1 2020 and has held it in 13 quarters since. The position peaked at $37.7M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 700,692 shares of Moderna worth $35.6M as of Q1 2026.
  • Moderna was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Moderna made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #566 holding.
  • Qube Research & Technologies (QRT) first reported a position in Moderna in Q1 2020 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Moderna position peaked at $37.7M in Q4 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.